AI-assisted, human-published
04/27/2026 /Startups/Founders
Flagship Pioneering Unveils Serif Biomedicines, Backed by $50 Million Investment
Flagship Pioneering launches Serif Biomedicines, a biotechnology company focused on utilizing Modified DNA as a novel type of medicines, with an initial commitment of $50 million.
AI-assisted, human-published
Latest headlines
-
-
-
Stay connected!
If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here
©2023 VentureCapital.com